Safety and Efficacy of AM712 in Patients with NAMD
NCT05345769
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration
Interventions
BIOLOGICAL:
AM712(ASKG712)
Sponsor
AffaMed Therapeutics Limited